Literature DB >> 2649445

Glucose tolerance and insulin response to glucose load in body builders.

M Szczypaczewska1, K Nazar, H Kaciuba-Uscilko.   

Abstract

To find out to what extent body composition affects glucose tolerance, blood glucose (BG) and insulin (IRI) responses to a 100-g oral glucose tolerance test (OGTT) were compared in 10 male body builders, 11 untrained lean control subjects, and 11 mildly obese men, all of similar age (19-35 years). In comparison with the remaining two groups, the body builders had the lowest percentage of fat, although their lean body mass (LBM) in absolute terms did not differ from that in obese subjects. Both BG and IRI concentrations during the OGTT were the lowest in body builders, medium in controls, and the highest in obese men. The differences in glucose tolerance between the groups were also demonstrated by comparison of the subjects' BG levels during the OGTT with the respective mean BG values obtained in a reference group of 42 healthy nonobese men aged from 20 to 55 years. The data indicate that body builders show better glucose tolerance and improved insulin action in comparison with untrained, nonobese subjects of similar age and body weight. Lean body mass in absolute terms cannot, however, be considered as a sole determinant of the insulin action in the body since in mildly obese subjects glucose tolerance was considerably reduced in spite of the fact that their LBM was similar to that in body builders. Either muscle hypertrophy or reduced adiposity may account for the beneficial effects of body building on glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649445     DOI: 10.1055/s-2007-1024870

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  8 in total

1.  Resistance training and insulin action in humans: effects of de-training.

Authors:  J L Andersen; P Schjerling; L L Andersen; F Dela
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

Review 2.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

3.  Resistance exercise at variable volume does not reduce postprandial lipemia in postmenopausal women.

Authors:  Cleiton Silva Correa; Bruno Costa Teixeira; Rodrigo Cauduro Oliveira Macedo; Aline Bittencourt; Renata Lopes Kruger; Julia Silveira Gross; Ronei Silveira Pinto; Alvaro Reischak-Oliveira
Journal:  Age (Dordr)       Date:  2014-01-12

Review 4.  Commercially marketed supplements for bodybuilding athletes.

Authors:  K K Grunewald; R S Bailey
Journal:  Sports Med       Date:  1993-02       Impact factor: 11.136

Review 5.  The effect of different training modes on skeletal muscle microvascular density and endothelial enzymes controlling NO availability.

Authors:  Matthew Cocks; Anton J M Wagenmakers
Journal:  J Physiol       Date:  2015-04-16       Impact factor: 5.182

6.  The effects of creatine supplementation on muscular performance and body composition responses to short-term resistance training overreaching.

Authors:  Jeff S Volek; Nicholas A Ratamess; Martyn R Rubin; Ana L Gómez; Duncan N French; Michael M McGuigan; Timothy P Scheett; Matthew J Sharman; Keijo Häkkinen; William J Kraemer
Journal:  Eur J Appl Physiol       Date:  2003-12-18       Impact factor: 3.078

7.  A counterintuitive perspective for the role of fat-free mass in metabolic health.

Authors:  Jean-Christophe Lagacé; Martin Brochu; Isabelle J Dionne
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-01-30       Impact factor: 12.910

8.  Lower maternal body condition during pregnancy affects skeletal muscle structure and glut-4 protein levels but not glucose tolerance in mature adult sheep.

Authors:  Paula M Costello; Lisa J Hollis; Roselle L Cripps; Natasha Bearpark; Harnish P Patel; Avan Aihie Sayer; Cyrus Cooper; Mark A Hanson; Susan E Ozanne; Lucy R Green
Journal:  Reprod Sci       Date:  2013-02-18       Impact factor: 3.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.